Júlia Oto

592 total citations
31 papers, 404 citations indexed

About

Júlia Oto is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Júlia Oto has authored 31 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Júlia Oto's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers), MicroRNA in disease regulation (5 papers) and Circular RNAs in diseases (5 papers). Júlia Oto is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers), MicroRNA in disease regulation (5 papers) and Circular RNAs in diseases (5 papers). Júlia Oto collaborates with scholars based in Spain, Germany and Belgium. Júlia Oto's co-authors include Pilar Medina, Álvaro Fernández‐Pardo, Emma Plana, Francisco España, Silvia Navarro, C.D. Vera Donoso, David Hervás, Manuel Miralles, Luis Ramón and Santiago Bonanad and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Júlia Oto

28 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Júlia Oto Spain 14 171 117 116 95 54 31 404
Álvaro Fernández‐Pardo Spain 12 151 0.9× 114 1.0× 51 0.4× 85 0.9× 44 0.8× 19 322
Ewa Kurzejamska Sweden 9 176 1.0× 104 0.9× 66 0.6× 50 0.5× 32 0.6× 15 390
Stephan Macher-Göppinger Germany 8 146 0.9× 37 0.3× 54 0.5× 56 0.6× 31 0.6× 16 311
Diane E. Lorant United States 9 136 0.8× 65 0.6× 148 1.3× 67 0.7× 46 0.9× 15 546
Alicia S. Eustes United States 9 160 0.9× 45 0.4× 114 1.0× 57 0.6× 31 0.6× 13 447
Cheung Wong United States 10 185 1.1× 125 1.1× 20 0.2× 37 0.4× 40 0.7× 18 385
Fazıl Aydin Türkiye 11 69 0.4× 38 0.3× 46 0.4× 88 0.9× 77 1.4× 32 345
Marjolein Meinders Netherlands 8 149 0.9× 27 0.2× 44 0.4× 54 0.6× 61 1.1× 12 401
Céline Bouvy Belgium 13 153 0.9× 80 0.7× 49 0.4× 25 0.3× 17 0.3× 30 421
Xin Luo China 14 309 1.8× 220 1.9× 52 0.4× 60 0.6× 64 1.2× 28 549

Countries citing papers authored by Júlia Oto

Since Specialization
Citations

This map shows the geographic impact of Júlia Oto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Júlia Oto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Júlia Oto more than expected).

Fields of papers citing papers by Júlia Oto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Júlia Oto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Júlia Oto. The network helps show where Júlia Oto may publish in the future.

Co-authorship network of co-authors of Júlia Oto

This figure shows the co-authorship network connecting the top 25 collaborators of Júlia Oto. A scholar is included among the top collaborators of Júlia Oto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Júlia Oto. Júlia Oto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oto, Júlia, Vânia M. Morelli, Kristian Hveem, et al.. (2025). Plasma miR-145-5p Levels and Risk of Future Cancer—Results from the HUNT Study. International Journal of Molecular Sciences. 26(5). 2191–2191. 1 indexed citations
3.
Oto, Júlia, Marta Roca, Emma Plana, et al.. (2024). Validation of urine p-cresol glucuronide as renal cell carcinoma non-invasive biomarker. Journal of Proteomics. 311. 105357–105357. 1 indexed citations
4.
Oto, Júlia, Sebastian Daniel Schäfer, Ludwig Kiesel, et al.. (2023). Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets. Cancers. 15(12). 3125–3125. 6 indexed citations
5.
Herreros‐Pomares, Alejandro, Júlia Oto, Pilar Medina, et al.. (2023). Neutrophil Extracellular Traps and Cancer: Trapping Our Attention with Their Involvement in Ovarian Cancer. International Journal of Molecular Sciences. 24(6). 5995–5995. 26 indexed citations
6.
Oto, Júlia, Emma Plana, Lourdes Cordón, et al.. (2023). Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro. Frontiers in Immunology. 14. 1171065–1171065. 16 indexed citations
8.
Vázquez‐Morón, Sonia, Álvaro Fernández‐Pardo, Júlia Oto, et al.. (2022). Applicability of the Thrombin Generation Test to Evaluate the Hemostatic Status of Hemophilia A Patients in Daily Clinical Practice. Journal of Clinical Medicine. 11(12). 3345–3345. 5 indexed citations
9.
Oto, Júlia, Álvaro Fernández‐Pardo, Marta Roca, et al.. (2022). LC–MS metabolomics of urine reveals distinct profiles for non-muscle-invasive and muscle-invasive bladder cancer. World Journal of Urology. 40(10). 2387–2398. 11 indexed citations
10.
Otero, Remedios, Verónica Sánchez‐López, Júlia Oto, et al.. (2022). Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study). Cancers. 14(11). 2771–2771. 7 indexed citations
12.
Oto, Júlia, Emma Plana, David Hervás, et al.. (2021). Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs. International Journal of Molecular Sciences. 22(15). 7913–7913. 11 indexed citations
13.
Oto, Júlia, Álvaro Fernández‐Pardo, Marta Roca, et al.. (2020). Urine metabolomic analysis in clear cell and papillary renal cell carcinoma: A pilot study. Journal of Proteomics. 218. 103723–103723. 29 indexed citations
14.
Oto, Júlia, Álvaro Fernández‐Pardo, David Hervás, et al.. (2020). A predictive model for prostate cancer incorporating PSA molecular forms and age. Scientific Reports. 10(1). 2463–2463. 24 indexed citations
15.
Plana, Emma, Júlia Oto, Pilar Medina, Álvaro Fernández‐Pardo, & Manuel Miralles. (2020). Novel contributions of neutrophils in the pathogenesis of abdominal aortic aneurysm, the role of neutrophil extracellular traps: A systematic review. Thrombosis Research. 194. 200–208. 31 indexed citations
16.
Oto, Júlia, Silvia Navarro, Anders Christian Larsen, et al.. (2020). MicroRNAs and Neutrophil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma. International Journal of Molecular Sciences. 21(3). 840–840. 33 indexed citations
17.
Oto, Júlia, Emma Plana, Álvaro Fernández‐Pardo, et al.. (2020). Urinary microRNAs: Looking for a New Tool in Diagnosis, Prognosis, and Monitoring of Renal Cancer. Current Urology Reports. 21(2). 11–11. 25 indexed citations
18.
Oto, Júlia, Álvaro Fernández‐Pardo, Manuel Miralles, et al.. (2019). Activated protein C assays: A review. Clinica Chimica Acta. 502. 227–232. 19 indexed citations
19.
Oto, Júlia, Emma Plana, David Hervás, et al.. (2019). Identification of a microRNA profile in urine with diagnostic and prognostic value for clear cell renal cell carcinoma. European Urology Supplements. 18(1). e89–e89. 2 indexed citations
20.
Ramón, Luis, Álvaro Fernández‐Pardo, Júlia Oto, et al.. (2017). Comparison of protocols and RNA carriers for plasma miRNA isolation. Unraveling RNA carrier influence on miRNA isolation. PLoS ONE. 12(10). e0187005–e0187005. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026